Medicaid brand-name drugs : rising prices are offset by manufacturer rebates.
- Physical Description: 1 online resource (iii, 22 pages) : illustrations
- Publisher: [Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2011.
|General Note:|| Title from title screen (viewed June 14, 2016).
|Bibliography, etc. Note:|| Includes bibliographical references.
Search for related items by subject
|Subject:||Medicaid > Costs.
Brand name products > Prices > United States.
Drugs > Prices > United States.
Pharmaceutical policy > United States.